Accumulating evidence has demonstrated increased TSPO expression during several neuroinflammatory conditions such as intracerebral hemorrhage and multiple sclerosis [8–11], suggesting that targeting TSPO may be a viable approach to limiting neuroinflammation and brain injury [12]. Here, TSPO is linked to intracerebral hemorrhage.